Author

Vijay Hadda

All India Institute of Medical SciencesORCID 0000-0001-5820-3685Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Amit Kumar Singh· 3 shared Hridayesh PrakashiD· 3 shared Niharika Sharma· 3 shared Abhishek Kumar· 2 shared Lalit Kumar SinghiD· 2 shared Anjaneya AyanuriD· 1 shared Rahul SharmaiD· 1 shared Rahul SharmaiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Amit Kumar Singh

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 20, 2026

Sphingosine-1-Phosphate Restrains Foamy Macrophage Formation and Modulates Inflammation in Multidrug-Resistant Tuberculosis

Abhishek Kumar, Niharika Sharma, Lalit Kumar Singh…·Hridayesh Prakash

This study investigates the role of sphingosine-1-phosphate (S1P) in modulating foamy macrophage formation and inflammation in multidrug-resistant tuberculosis (MDR-TB).

DOI 10.64898/2026.10.15.759318

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologybioRxivPreprintSep 3, 2026

L-Serine and Palmitoyl CoA control Mycobacterial infection by tweaking protective immune response: A potential host directed therapy for tuberculosis

Niharika Sharma, Rahul Sharma, Abhishek Kumar…·Hridayesh Prakash

This study investigates the role of L-Serine and palmitoyl CoA in enhancing the immune response against Mycobacterium tuberculosis, showing improved bacterial clearance and tissue recovery in murine models.

DOI 10.64898/2026.08.20.745965

mouseproteomics

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintMar 17, 2025

ATLS2021-PA (A Sphingolipid mimetic): Upcoming Host Directed Therapy for Acute and MDR Tuberculosis

Niharika Sharma, Rahul Sharma, Vijay Hadda…·Hridayesh Prakash

This paper demonstrates that ATLS2021 enhances sphingolipid levels and improves anti-tubercular efficacy, including sensitizing MDR TB to Rifampicin and inducing immunogenic responses.

DOI 10.1101/2025.03.17.643690

humanproteomics

𝕏 PostBluesky